Update on the phase 1 trial of Nelmastobart in patients with advanced solid tumors

Authors
Category Primary study
JournalMOLECULAR CANCER THERAPEUTICS
Year 2023
This article has no abstract
Epistemonikos ID: 7da3b0c12a758a310c11adf079e99dfd760ec123
First added on: Feb 17, 2025